About CAD Therapeutics
CAD Therapeutics is a private company based in New York, New York. It has reported $4,000,000 raised in one offering on Form D since October 2026. Its chief executive is Christopher Teas.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Oct 2, 2026 | $4,000,000of $10.0M target | 2 | $2.0M | Equity, SERIES A COMMON STOCKRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CAD Therapeutics's Form D filed Oct 2, 2026.
CT
Christopher Teas
Chief Executive Officer, CAD Therapeutics
SB
Sorina Buri
Director